How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/adolescent-males-with-hypogonadotropic-hypogonadism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Adolescent males with hypogonadotropic hypogonadism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adolescent males with hypogonadotropic hypogonadism (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Adolescent males with hypogonadotropic hypogonadism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Org 36286	CORIFOLLITROPIN ALFA	Merck Sharp & Dohme Limited		Follicle-stimulating hormone receptor		2010-01-01
Elonva	Elonva	University Medical Centre Ljubljana		Follicle-stimulating hormone receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck Sharp & Dohme Limited · 1 drug in Adolescent males with hypogonadotropic hypogonadism
University Medical Centre Ljubljana · 1 drug in Adolescent males with hypogonadotropic hypogonadism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Adolescent males with hypogonadotropic hypogonadism:

Cite this brief

Drug Landscape (2026). Adolescent males with hypogonadotropic hypogonadism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/adolescent-males-with-hypogonadotropic-hypogonadism. Accessed 2026-06-10.

Adolescent males with hypogonadotropic hypogonadism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing